Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07348172 · ClinicalTrials.gov registry record · Early Phase 1
Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings
A Early Phase 1 study, sponsored by Stanford University.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 100
- Enrollment target
NCT07348172: Clinical Trial Early Phase 1 study, sponsored by Stanford University.
NCT07348172 is a Early Phase 1 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 100 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07348172, a Early Phase 1 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
Primary Outcome
Change in drug liking rating (0-100), anchored by divert "not at all=0" and "as much as possible=100".
Interventions
- DRUG Placebo
- DRUG Amisulpride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-03-01 |
| Est. Completion | 2028-03-31 |
| Phase | Early Phase 1 |
What is known before NCT07348172 opens enrollment
NCT07348172 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (89% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07348172 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07348172 about?
NCT07348172 is a clinical study titled "Characterizing Drug Liking During Drug Administration in Peri-procedural Clinical Settings". The purpose of this study is to evaluate whether medications used in peri-procedural clinical settings can modulate drug liking.
What is the current status of trial NCT07348172?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 100 participants. The study started on 2026-03-01. Estimated completion is 2028-03-31.
What interventions are being tested in trial NCT07348172?
The interventions under investigation include: Placebo (DRUG), Amisulpride (DRUG).
Who is sponsoring clinical trial NCT07348172?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07348172's enrollment target sits among peer trials
100 184th of 2000 higher than 1,782 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI